SHUNSUKE TAKAHAGI

Last Updated :2024/02/01

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medical), Associate Professor
E-mail
shunstkhiroshima-u.ac.jp
Other Contact Details
1-2-3 Kasumi, Minami-ku, Hiroshima, Japan, Japan
TEL : (+81)82-257-5238 FAX : (+81)
Self-introduction
He is working in the clinical practice and research on skin allergy

Basic Information

Major Professional Backgrounds

  • 2016/03/01, 2019/03/31, Hiroshima University, Institute of Biomedical & Health Sciences, Assistant Professor

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical Sciences, Japan, 2006/04, 2010/03

Academic Degrees

  • Hiroshima University

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Dermatology

Research Keywords

  • Skin allergy
  • urticaria
  • regeneration of skin appendages

Affiliated Academic Societies

  • The Japanese Dermatological Association
  • Japanese society of allergology

Educational Activity

Course in Charge

  1. 2023, Undergraduate Education, Year, Clinical diagnosis and treatment II
  2. 2023, Undergraduate Education, Intensive, Practice for medical research
  3. 2023, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2023, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2023, Undergraduate Education, First Semester, Dermatology

Research Activities

Academic Papers

  1. Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthood., 2021
  2. Temporary wheat allergy in the postpartum period., 2021
  3. Long-term remission of severe livedoid vasculopathy treated with a short course of intravenous immunoglobulin., 2021
  4. Iatrogenic cutaneous lymphoid hyperplasia induced by squaric acid dibutyl ester., 2021
  5. Impact of physicians' clinical experience and workplace on patients' care of urticaria in Japan: A sub-analysis of a nation-wide cross-sectional web questionnaire survey., 2021
  6. Pemphigus foliaceus with inconsistent findings between clinical features and titres of antidesmoglein autoantibodies., 2021
  7. The relationship between the development of erythroderma in patients with atopic dermatitis and the avoidance of anti-inflammatory topical drugs., 2021
  8. Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019, JOURNAL OF DERMATOLOGY, 49(7), 724-728, 202207
  9. Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis, DERMATOLOGIC THERAPY, 35(7), 202207
  10. Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome, JOURNAL OF DERMATOLOGY, 49(6), 666-670, 202206
  11. Coagulation factors induce human skin mast cell and basophil degranula-tion via activation of complement 5 and the C5a receptor, JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 147(3), 1101-+, 202103
  12. Clinical course of more than 10 years in a patient with extensive skin burns who received cultured epidermal autograft transplantation, REGENERATIVE THERAPY, 19, 154-157, 202203
  13. A human monoclonal IgE antibody that binds to MGL_1304, a major allergen in human sweat, without activation of mast cells and basophils, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 468(1-2), 99-104, 20151204
  14. Evaluation of skin perfusion pressure to assess refractory foot ulcers, JOURNAL OF WOUND CARE, 26(5), 267-270, 201705
  15. Contact urticaria syndrome with IgE antibody against a cefotiam-unique structure, evoked by nonapparent exposure to cefotiam, CLINICAL AND EXPERIMENTAL DERMATOLOGY, 42(5), 527-531, 201707
  16. Impedance-Based Living Cell Analysis for Clinical Diagnosis of Type I Allergy, SENSORS, 17(11), 201711
  17. Staphylococcus aureus from atopic dermatitis skin alters cytokine production triggered by monocyte-derived Langerhans cell., J Dermatol Sci., 201712
  18. Chronic spontaneous urticaria and the extrinsic coagulation system, ALLERGOLOGY INTERNATIONAL, 67(2), 191-194, 201804
  19. Sweat allergy, ALLERGOLOGY INTERNATIONAL, 67(4), 435-441, 201810
  20. Activation of Human Peripheral Basophils in Response to High IgE Antibody Concentrations without Antigens, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(1), 20190101
  21. Histamine and Toll-like receptor ligands synergistically induce endothelial cell gap formation by the extrinsic coagulating pathway, JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 141(3), 1115-1118, 201803
  22. A single reaction-diffusion equation for the multifarious eruptions of urticaria, PLOS COMPUTATIONAL BIOLOGY, 16(1), 202001
  23. Type-I-hypersensitivity to 15 kDa, 28 kDa and 54 kDa proteins in vitellogenin specific to Gadus chalcogrammus roe, ALLERGOLOGY INTERNATIONAL, 69(2), 253-260, 202004
  24. Roles of omalizumab in various allergic diseases, ALLERGOLOGY INTERNATIONAL, 69(2), 167-177, 202004
  25. Randomized double-blind cross-over trial of bath additive containing tannic acid in patients with atopic dermatitis, JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 3(3), 56-61, 202006
  26. Rechallenge of programmed cell death 1 inhibitor after an interval with dacarbazine treatment may be effective for advanced malignant melanoma, JOURNAL OF DERMATOLOGY, 47(8), 907-910, 202008
  27. Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-alpha, interleukin (IL)-33 or IL-1 beta, JOURNAL OF DERMATOLOGY, 47(11), 1293-1300, 202011
  28. Calculation of practical skin donor area for meshed skin grafting in real-world surgery, DERMATOLOGIC THERAPY, 33(6), 202011
  29. Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria, JOURNAL OF DERMATOLOGY, 48(1), 56-63, 202101
  30. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria, ALLERGY, 76(3), 816-830, 202103
  31. Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria, ALLERGY, 75(4), 971-974, 202004
  32. The Role of Coagulation and Complement Factors for Mast Cell Activation in the Pathogenesis of Chronic Spontaneous Urticaria, CELLS, 10(7), 202107
  33. A case of millet allergy that developed into wheat-induced anaphylaxis by cross-reaction between millet and wheat antigens., Allergol Int., 69(3), 471-473, 20200118
  34. Case of anaphylaxis to maltose solution., J Dermatol., 47(4), e107-e108, 202004
  35. Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicin., Eur J Hosp Pharm., 27(2), 128-128, 202003
  36. Grover's disease successfully treated with calcipotriene/betamethasone dipropionate ointment., Dermatol Ther., 33(6), e14217-e14217, 202011
  37. Malignant melanoma with in-transit metastases refractory to programmed cell death-1 inhibitor successfully treated with local interferon-beta injections: A case report, MOLECULAR AND CLINICAL ONCOLOGY, 15(4), 202110
  38. Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan, JOURNAL OF DERMATOLOGY, 48(10), 1602-1606, 202110
  39. A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL), ALLERGOLOGY INTERNATIONAL, 70(4), 471-479, 202110
  40. Long-term remission of severe livedoid vasculopathy treated with a short course of intravenous immunoglobulin., 2021

Invited Lecture, Oral Presentation, Poster Presentation

  1. The Japanese version of Patient Reported Outcome measures in Angioedema., 2021/12/10, Without Invitation, Japanese
  2. A cross-sectional epidemiological analysis of 1061 patients with urticaria in Japan., 2021/12/10, Without Invitation, Japanese
  3. Review and perspective of allergic skin diseases associated with sweating, 2021/12/10, Without Invitation, Japanese
  4. Randomized double-blind cross-over trial of bath additive containing tannic acid in patients with atopic dermatitis., 2021/11/26, Without Invitation, Japanese

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI, 2010, 2011
  2. 2017, 2019
  3. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2017, 2019

Social Activities

Organizing Academic Conferences, etc.

  1. The 40th annual meeting pf the japanese society of pediatric dermatology, 2016/07, 2016/07
  2. 2018/05, 2018/06

History as Peer Reviews of Academic Papers

  1. 2018, Journal of Dermatology